These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9389941)

  • 1. AIDS and leishmaniasis.
    Davidson RN
    Genitourin Med; 1997 Aug; 73(4):237-9. PubMed ID: 9389941
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS).
    Pourahmad M; Hooshmand F; Rahiminejad M
    Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India.
    Thakur CP; Sinha PK; Singh RK; Hassan SM; Narain S
    Trans R Soc Trop Med Hyg; 2000; 94(6):696-7. PubMed ID: 11198660
    [No Abstract]   [Full Text] [Related]  

  • 4. Engima of therapeutic failure in visceral leishmaniasis.
    Arya SC
    J Assoc Physicians India; 1993 Mar; 41(3):155-8. PubMed ID: 8226600
    [No Abstract]   [Full Text] [Related]  

  • 5. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Santos J; Rivero A; Márquez M
    An Med Interna; 2000 Oct; 17(10):562-3. PubMed ID: 11109659
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and tolerance of amphotericin B in a lipid emulsion in the treatment of visceral leishmaniasis in AIDS patients.
    Petit N; Parola P; Dhiver C; Gastaut JA
    J Antimicrob Chemother; 1996 Jul; 38(1):154-7. PubMed ID: 8858471
    [No Abstract]   [Full Text] [Related]  

  • 8. Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients.
    Angarano G; Maggi P; Coppola SL; Cavaliere RL
    Eur J Clin Microbiol Infect Dis; 1998 May; 17(5):365-7. PubMed ID: 9721971
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of visceral Leismaniasis in HIV patients with a new regimen of liposomal amphotericin].
    Canora Lebrato J; Troncoso García E; Escobar T; Hernández Quero J
    Med Clin (Barc); 2001 Mar; 116(10):395. PubMed ID: 11333677
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutaneous manifestations of visceral leishmaniasis resistant to liposomal amphotericin B in an HIV-positive patient.
    Alsina-Gibert M; López-Lerma I; Martinez-Chamorro E; Herrero-Mateu C
    Arch Dermatol; 2006 Jun; 142(6):787-9. PubMed ID: 16785393
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of an Itraconazole/allopurinol combination for the treatment of visceral leishmaniasis in a patient with AIDS.
    Raffi F; Merrien D; Le Pape P; Reliquet V
    Clin Infect Dis; 1995 Nov; 21(5):1338-9. PubMed ID: 8589174
    [No Abstract]   [Full Text] [Related]  

  • 12. [Leishmaniasis. Basic principles, clinical aspects, diagnosis and therapy].
    Burbach G; May J; Harms G; Bienzle U
    Dtsch Med Wochenschr; 1999 Jan; 124(4):88-93. PubMed ID: 10071606
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful use of miltefosine and sodium stibogluconate, in combination, for the treatment of an HIV-positive patient with visceral leishmaniasis: a case report and brief review of the literature.
    Collini P; Premchand N; Lockwood D; Greig J
    Ann Trop Med Parasitol; 2009 Jul; 103(5):455-9. PubMed ID: 19583915
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of intermittent liposomal amphotericin B in the treatment of visceral leishmaniasis in patients infected with human immunodeficiency virus.
    Laguna F; Torre-Cisneros J; Moreno V; Villanueva JL; Valencia E
    Clin Infect Dis; 1995 Sep; 21(3):711-2. PubMed ID: 8527591
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature.
    Rybniker J; Goede V; Mertens J; Ortmann M; Kulas W; Kochanek M; Benzing T; Arribas JR; Fätkenheuer G
    Int J Infect Dis; 2010 Jun; 14(6):e522-5. PubMed ID: 19726213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of visceral leishmaniasis: efficacy and limits of miltefosine].
    Gangneux JP; Marty P
    Sante; 2001; 11(4):257-8. PubMed ID: 11861203
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV-associated visceral leishmaniasis.
    Pintado V; López-Vélez R
    Clin Microbiol Infect; 2001 Jun; 7(6):291-300. PubMed ID: 11442562
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute pancreatitis associated with sodium stibogluconate treatment in a patient with human immunodeficiency virus.
    Domingo P; Ferrer S; Kolle L; Muñoz C; Rodriguez P
    Arch Intern Med; 1996 May; 156(9):1029, 1032. PubMed ID: 8624172
    [No Abstract]   [Full Text] [Related]  

  • 19. The irreplaceable image: Acute toxicity in erythroid bone marrow progenitors after antimonial therapy.
    Hernández JA; Navarro JT; Force L
    Haematologica; 2001 Dec; 86(12):1319. PubMed ID: 11726328
    [No Abstract]   [Full Text] [Related]  

  • 20. Challenges in HIV and visceral Leishmania co-infection: future research directions.
    Ejara ED; Lynen L; Boelaert M; Van Griensven J
    Trop Med Int Health; 2010 Oct; 15(10):1266-7. PubMed ID: 20723183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.